16425-99-3 Usage
Uses
Used in Organic Synthesis:
1-(2-phenylethyl)-2-(phenylsulfonyl)benzene is used as a building block in organic synthesis for the creation of various functionalized organic molecules. Its unique structure allows for the development of a wide range of compounds with different properties and applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(2-phenylethyl)-2-(phenylsulfonyl)benzene is utilized as a key component in the synthesis of new drugs and biologically active compounds. Its sulfonyl and phenylethyl groups provide a foundation for designing molecules with specific therapeutic effects.
Used in Material Science:
1-(2-phenylethyl)-2-(phenylsulfonyl)benzene is also studied for its potential applications in material science. Its properties may contribute to the development of new materials with unique characteristics, such as improved strength, flexibility, or chemical resistance.
Used as a Precursor for Multifunctional Polymers:
1-(2-phenylethyl)-2-(phenylsulfonyl)benzene serves as a precursor in the synthesis of multifunctional polymers. The incorporation of 1-(2-phenylethyl)-2-(phenylsulfonyl)benzene into polymer structures can lead to materials with enhanced performance and a broader range of applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 16425-99-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,4,2 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16425-99:
(7*1)+(6*6)+(5*4)+(4*2)+(3*5)+(2*9)+(1*9)=113
113 % 10 = 3
So 16425-99-3 is a valid CAS Registry Number.
16425-99-3Relevant academic research and scientific papers
ARYL-SULFONAMIDE AND ARYL-SULFONE DERIVATIVES AS TRPML MODULATORS
-
, (2018/12/03)
The new arylsulfonamide and arylsulfone derivatives are modulators of TRPML and are useful in treating disorders related to TRPML activities and lysosome functions such as acid-related disorders and cancer.
